Literature DB >> 32035104

Therapeutic applications of lytic phages in human medicine.

Zhimin Guo1, Hua Lin1, Xufeng Ji1, Guangmou Yan2, Liancheng Lei2, Wenyu Han2, Jingmin Gu3, Jing Huang4.   

Abstract

The emergence and spread of antibiotic-resistant bacteria constitute a critical issue for modern medicine. Patients with antibiotic-resistant bacterial infections consume more healthcare resources and have worse clinical outcomes than patients with antibiotic-sensitive bacterial infections. Phages are natural predators of bacteria and may therefore be a source of useful antibacterial drugs. Phage therapy possess availability for oral administration, penetration through the bacteria cell wall, and eradication bacterial biofilms. All of these advantages give phage therapy the possibility to turn into applications for infectious diseases. In this mini-review, we focus on the brief history of lytic phage therapy, the life cycles of lytic phages and the therapeutic effects of lytic phages.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  Bacteria; Lytic phage; Phage; Phage therapy

Year:  2020        PMID: 32035104     DOI: 10.1016/j.micpath.2020.104048

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  6 in total

1.  A Diverse Panel of Clinical Acinetobacter baumannii for Research and Development.

Authors:  Madeline R Galac; Erik Snesrud; Francois Lebreton; Jason Stam; Michael Julius; Ana C Ong; Rosslyn Maybank; Anthony R Jones; Yoon I Kwak; Kate Hinkle; Paige E Waterman; Emil P Lesho; Jason W Bennett; Patrick Mc Gann
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

Review 2.  What Are the Potential Benefits of Using Bacteriophages in Periodontal Therapy?

Authors:  Jan Kowalski; Renata Górska; Martyna Cieślik; Andrzej Górski; Ewa Jończyk-Matysiak
Journal:  Antibiotics (Basel)       Date:  2022-03-25

3.  Assessment of Phage-Mediated Inhibition and Removal of Multidrug-Resistant Pseudomonas aeruginosa Biofilm on Medical Implants.

Authors:  Stephen Amankwah; Mekonen Adisu; Kasahun Gorems; Kedir Abdella; Tesfaye Kassa
Journal:  Infect Drug Resist       Date:  2022-05-31       Impact factor: 4.177

4.  Case Report: Chronic Bacterial Prostatitis Treated With Phage Therapy After Multiple Failed Antibiotic Treatments.

Authors:  Apurva Virmani Johri; Pranav Johri; Naomi Hoyle; Levan Pipia; Lia Nadareishvili; Dea Nizharadze
Journal:  Front Pharmacol       Date:  2021-06-10       Impact factor: 5.810

5.  Comparison between American and European legislation in the therapeutical and alimentary bacteriophage usage.

Authors:  Zakira Naureen; Daniele Malacarne; Kyrylo Anpilogov; Astrit Dautaj; Giorgio Camilleri; Stefano Cecchin; Simone Bressan; Arianna Casadei; Elena Albion; Elisa Sorrentino; Tommaso Beccari; Munis Dundar; Matteo Bertelli
Journal:  Acta Biomed       Date:  2020-11-09

6.  Safety and Efficacy of a Phage, kpssk3, in an in vivo Model of Carbapenem-Resistant Hypermucoviscous Klebsiella pneumoniae Bacteremia.

Authors:  Yunlong Shi; Yuan Peng; Yixin Zhang; Yu Chen; Cheng Zhang; Xiaoqiang Luo; Yajie Chen; Zhiqiang Yuan; Jing Chen; Yali Gong
Journal:  Front Microbiol       Date:  2021-05-20       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.